The PRISM research study is a medical research study of an investigational medication for people who have severe itch because of Prurigo Nodularis. (Prurigo Nodularis is also known as Nodular Prurigo.)
This research study is currently enrolling adults suffering from chronic severely itchy bumps on the skin.
To learn more or to see if there is a PRISM research study location near you, scroll down or click on the page links.
To see if you or someone you may know may be able to participate, please complete our pre-qualifying questionnaire.
Any person with itch from Prurigo Nodularis who is 18 years of age or older.
These questions are directed to the person who would participate in the research study if they qualify, so "you" as used in the pre-qualifying questionnaire refers to that person.
No. You may take the pre-qualifying questionnaire just to see if you might pre-qualify. Also, participation in a research study is completely voluntary at every step in the process.
Why is this Medical Research Study Important?
Prurigo Nodularis is defined by the presence of distinctive bumps (nodules) on the skin which can be very itchy and cause the intense desire to scratch. This itching is highly bothersome and is associated with sleep problems, depression, and the lack of ability to do things that are enjoyed. Currently, there is no approved treatment specifically for itching associated with Prurigo Nodularis. Therefore, finding new treatment options for people with this condition is extremely important.
Before new medications can be approved for public use, they must be tested in research studies like this one. This study will look at the safety and effectiveness of the study medication on the treatment of itching related to Prurigo Nodularis and will also evaluate the effect of the study medication on itch-related quality of life and sleep quality.
Although there are many definitions, a research study is generally considered to be health-related medical research in people with a specific condition using a pre-defined written protocol.
Click here to learn more about clinical research.